Gene-Editing Co. Synthego Hits Ch. 11 With Sights On A Sale
By Yun Park · May 6, 2025, 11:03 AM EDT
California-based biotechnology company Synthego Corp. filed for Chapter 11 in Delaware bankruptcy court, listing up to $500 million in debt and outlining a plan to sell its assets during the proceedings....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login